TB
Healthcare & Life Sciences
Turnstone Biologics
United States
Turnstone Biologics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Turnstone Biologics
Turnstone Biologics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Turnstone Biologics develops oncolytic virus-based immunotherapies that engineer viral vectors to stimulate anti-tumor immune responses and deliver immunomodulatory payloads for cancer treatment.
Explore Turnstone Biologics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.